Lymph node-targeting tracer pinpoints more metastatic breast cancer

March 26, 2013

The newly approved imaging agent, Lymphoseek, sought out 94 percent of found breast cancer metastases to the sentinel lymph nodes, according to a study published in the March edition of the Annals of Surgical Oncology.

Anne M. Wallace, MD, chief of plastic surgery, from the University of California, San Diego School of Medicine, and colleagues, described a phase 3 trial focused on the comparative evaluation of [99mTc]Tilmanocept for sentinel lymph node mapping in breast cancer patients.